News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Chodakewitz Jeffrey
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/16/2023 |
4
| Chodakewitz Jeffrey (Director) has filed a Form 4 on Adicet Bio, Inc.|
Txns:
| Disposed/sold 30,000 options to buy
@ $16.11, valued at
$483.3k
Granted 30,000 options to buy
@ $0
Disposed/sold 18,500 options to buy
@ $15.93, valued at
$294.7k
Granted 18,500 options to buy
@ $0
Disposed/sold 18,500 options to buy
@ $11.49, valued at
$212.6k
Disposed/sold 26,400 options to buy
@ $5.195, valued at
$137.1k
Granted 26,400 options to buy
@ $0 |
|
| 06/16/2023 |
4
| Chodakewitz Jeffrey (Director) has filed a Form 4 on Schrodinger, Inc.|
Txns:
| Granted 6,250 shares
@ $0
Granted 12,500 options to buy
@ $45.26, valued at
$565.8k
|
|
| 06/02/2023 |
4
| Chodakewitz Jeffrey (Director) has filed a Form 4 on Adicet Bio, Inc.|
Txns:
| Granted 5,900 shares
@ $0
Granted 26,400 options to buy
@ $5.195, valued at
$137.1k
|
|
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2022 |
4
| Chodakewitz Jeffrey (Director) has filed a Form 4 on Praxis Precision Medicines, Inc.|
Txns:
| Granted 22,753 options to buy
@ $8.38, valued at
$190.7k
|
|
| 06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2021 |
4
| Chodakewitz Jeffrey (Director) has filed a Form 4 on Adicet Bio, Inc.|
Txns:
| Granted 18,500 options to buy
@ $15.93, valued at
$294.7k
|
|
| 04/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/15/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/17/2020 |
4
| Chodakewitz Jeffrey (Director) has filed a Form 4 on Adicet Bio, Inc.|
Txns:
| Granted 30,000 options to buy
@ $16.11, valued at
$483.3k
|
|
| 06/05/2020 |
4
| Chodakewitz Jeffrey (Director) has filed a Form 4 on resTORbio, Inc.|
Txns:
| Granted 14,414 options to buy
@ $2.23, valued at
$32.1k
|
|
| 05/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/11/2019 |
4
| Chodakewitz Jeffrey (Director) has filed a Form 4 on TETRAPHASE PHARMACEUTICALS INC|
Txns:
| Granted 16,500 options to buy
@ $0.77, valued at
$12.7k
|
|
| 05/09/2019 |
4
| Chodakewitz Jeffrey (Director) has filed a Form 4 on resTORbio, Inc.|
Txns:
| Granted 14,414 options to buy
@ $7.99, valued at
$115.2k
|
|
| 08/15/2018 |
4
| Chodakewitz Jeffrey (Director) has filed a Form 4 on resTORbio, Inc.|
Txns:
| Granted 28,828 options to buy
@ $10.42, valued at
$300.4k
|
|
| 08/15/2018 |
3
| Chodakewitz Jeffrey (Director) has filed a Form 3 on resTORbio, Inc. |
| 06/01/2018 |
4
| Chodakewitz Jeffrey (Director) has filed a Form 4 on TETRAPHASE PHARMACEUTICALS INC|
Txns:
| Granted 12,500 options to buy
@ $3.68, valued at
$46k
|
|
| 04/02/2018 |
4
| Chodakewitz Jeffrey (EVP) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA |
| 02/14/2018 |
4
| Chodakewitz Jeffrey (EVP GMDA, CMO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 1,300 shares
@ $149.21, valued at
$194k
Sold 1,100 shares
@ $150.47, valued at
$165.5k
Sold 2,022 shares
@ $151.26, valued at
$305.8k
Sold 400 shares
@ $152.62, valued at
$61k
Sold 300 shares
@ $153.69, valued at
$46.1k
|
|
| 02/08/2018 |
4
| Chodakewitz Jeffrey (EVP GMDA, CMO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Granted 12,136 shares
@ $0
Granted 10,125 shares
@ $0
Granted 23,479 options to buy
@ $155.57, valued at
$3.7M
|
|
| 02/07/2018 |
4
| Chodakewitz Jeffrey (EVP GMDA, CMO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 494 shares
@ $158.32, valued at
$78.2k
Sold 700 shares
@ $159.62, valued at
$111.7k
Sold 500 shares
@ $160.5, valued at
$80.3k
Sold 500 shares
@ $161.51, valued at
$80.8k
Sold 400 shares
@ $162.94, valued at
$65.2k
Sold 900 shares
@ $164.12, valued at
$147.7k
Sold 100 shares
@ $164.71, valued at
$16.5k
Exercised 3,594 options to buy
@ $109.14, valued at
$392.2k
|
|
| 02/05/2018 |
4
| Chodakewitz Jeffrey (EVP GMDA, CMO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 1,900 shares
@ $167.44, valued at
$318.1k
Sold 600 shares
@ $165.23, valued at
$99.1k
Sold 996 shares
@ $166.1, valued at
$165.4k
Sold 100 shares
@ $168.06, valued at
$16.8k
Sold 100 shares
@ $169.49, valued at
$16.9k
Exercised 1,796 options to buy
@ $91.05, valued at
$163.5k
|
|
| 01/17/2018 |
4
| Chodakewitz Jeffrey (EVP GMDA, CMO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 519 shares
@ $155.8, valued at
$80.9k
Sold 900 shares
@ $157.54, valued at
$141.8k
Sold 300 shares
@ $159.04, valued at
$47.7k
Exercised 1,719 options to buy
@ $96.87, valued at
$166.5k
|
|
| 01/03/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/06/2017 |
4
| Chodakewitz Jeffrey (EVP GMDA, CMO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 400 shares
@ $143.54, valued at
$57.4k
Sold 1,096 shares
@ $144.89, valued at
$158.8k
Sold 300 shares
@ $145.89, valued at
$43.8k
Sold 3,594 shares
@ $144.69, valued at
$520k
Exercised 1,796 options to buy
@ $91.05, valued at
$163.5k
Exercised 3,594 options to buy
@ $109.14, valued at
$392.2k
|
|
| 10/31/2017 |
4
| Chodakewitz Jeffrey (EVP GMDA, CMO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 1,400 shares
@ $142.38, valued at
$199.3k
Sold 4,100 shares
@ $143.46, valued at
$588.2k
Sold 25,784 shares
@ $144.46, valued at
$3.7M
Sold 19,016 shares
@ $145.26, valued at
$2.8M
Sold 4,700 shares
@ $146.52, valued at
$688.6k
Sold 3,400 shares
@ $147.75, valued at
$502.4k
Sold 1,400 shares
@ $148.4, valued at
$207.8k
Sold 200 shares
@ $149.34, valued at
$29.9k
|
|
| 10/18/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/04/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/04/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|
|